Let me ask you a question, okay? I know you (or anyone here) don't answer me seriously, but I will still ask.
If I was Big Pharma or even a medium sized biotech and I saw a company like RadioGel, wouldn't you think I would have had signed an agreement to either;
(a) fund all or partial the expenses for future rights?
(b) acquired the patents and/or "company" years ago?
Now ask yourself, why would such a "revolutionary" device sit dormant for over 20 years? Does that really make sense to you?
Guess what, in that time, other companies now have the ability and know-how to create the product.
What people still don't seem to get is;
(a) the radioisotope is a "generic" drug
(b) the injectable device is a "generic" applicator
(c) the polymer composite is now a "generic" carrier
There is no need to license, patent or pay royalties to anyone. The only thing missing is the FDA approval.
A class 3 medical device should take a few years at most to get market clearance. Unlike new drugs.
Even if RadioGel gets cleared, there is a line of people who can (and might) just develop their own "generic" device.
Market Data 
Markets 
